🔗 Share this article

An underground market for unlicensed weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Content Elimination

Based on the social media company, the service has removed violative content and banned related keywords and query recommendations. The organization said it was committed to keeping the service secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to nine thousand members selling retatrutide using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up channels with thousands of users, filled with images of slimming results, positive reviews and step-by-step guides for mixing or administering at home.

After minutes of entering one group, a vendor posted contact information, where most transactions take place. The vendor provided an guidebook and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages show black plastic packages with postal service labels, stating to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service said it regularly moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Although the research behind retatrutide is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may subject users to potentially significant health risks”.